Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Ketoconazole“
Suchtreffer
Begriffe & Kennungen
Jinarc · 4.5 · Co-administration of tolvaptan and ketoconazole resulted in a 440 % increase in area under time- concentration
Eintrag öffnenJorveza · 4.5 · Co-treatment with potent CYP3A inhibitors such as ketoconazole, ritonavir, itraconazole, clarithromycin, cobic
Eintrag öffnenJorveza · 4.5 · Co-treatment with potent CYP3A inhibitors such as ketoconazole, ritonavir, itraconazole, clarithromycin, cobic
Eintrag öffnenJorveza · 4.5 · Ketoconazole 200 mg once daily orally increased the plasma concentration of budesonide (3 mg single dose) appr
Eintrag öffnenJorveza · 4.5 · Ketoconazole 200 mg once daily orally increased the plasma concentration of budesonide (3 mg single dose) appr
Eintrag öffnenJuluca · 4.5 · Ketoconazole AUC ↓ 24% Cmin ↓ 66% Cmax ↔ (induction of CYP3A due to high rilpivirine dose in the study).
Eintrag öffnenJuluca · 4.5 · Ketoconazole/ Rilpivirine Rilpivirine1,2 AUC ↑ 49% Cmin ↑ 76% Cmax ↑ 30% (inhibition of CYP3A enzymes).
Eintrag öffnenKaftrio · 4.5 · 41 • ketoconazole, itraconazole, posaconazole and voriconazole • telithromycin and clarithromycin
Eintrag öffnenKaftrio · 4.5 · Examples of strong CYP3A inhibitors include: • ketoconazole, itraconazole, posaconazole and voriconazole • tel
Eintrag öffnenKalydeco · 4.5 · Ivacaftor is a sensitive CYP3A substrate. Co-administration with ketoconazole, a strong CYP3A inhibitor, incre
Eintrag öffnenKalydeco · 4.5 · Ivacaftor is a sensitive CYP3A substrate. Co-administration with ketoconazole, a strong CYP3A inhibitor, incre
Eintrag öffnenKetoconazol
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA)
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.1 Therapeutic indications · 1
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.3 Contraindications · 1
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1; - Hypersensitivi
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.3 · 4 o colchicine in patients with renal impairment due to an increased risk of severe adverse reactions; o irino
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.3 · The list above is not an inclusive list of compounds that may interact with ketoconazole and result in potenti
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnen